These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 48968)

  • 1. Letter: Dyskinesias during levodopa therapy.
    Tolosa ES; Maritn WE; Cohen HP
    Lancet; 1975 Jun; 1(7921):1381-2. PubMed ID: 48968
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: Diphasic dyskinesia during levodopa therapy.
    Barbeau A
    Lancet; 1975 Mar; 1(7909):756. PubMed ID: 47527
    [No Abstract]   [Full Text] [Related]  

  • 3. "On-off" effects in patients with Parkinson's disease on chronic levodopa therapy.
    Marsden CD; Parkes JD
    Lancet; 1976 Feb; 1(7954):292-6. PubMed ID: 55599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous dopaminergic stimulation for Parkinson's disease: facts and fancy.
    Obeso JA; Grandas F; Vaamonde J; Luquin MR; Martinez-Lage JM
    Funct Neurol; 1988; 3(4):413-27. PubMed ID: 3072277
    [No Abstract]   [Full Text] [Related]  

  • 5. Variations in the "on-off" effect.
    Yahr MD
    Adv Neurol; 1974; 5():397-9. PubMed ID: 4440587
    [No Abstract]   [Full Text] [Related]  

  • 6. Deanol in the treatment of levodopa-induced dyskinesias.
    Klawans HL; Topel JL; Bergen D
    Neurology; 1975 Mar; 25(3):290-3. PubMed ID: 1167639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma dopa concentrations and the "on-off" effect after chronic treatment of Parkinson's disease.
    Sweet RD; McDowell FH
    Neurology; 1974 Oct; 24(10):953-6. PubMed ID: 4472237
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of etybenzatropine and diazepam on levodopa-induced diphasic dyskinesias in Parkinson's disease.
    Pourcher E; Bonnet AM; Kefalos J; Dubois B; Agid Y
    Mov Disord; 1989; 4(3):195-201. PubMed ID: 2779590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Problems in the administration of L-DOPA (author's transl)].
    Ferrari E
    Riv Patol Nerv Ment; 1974 Aug; 95(4):239-50. PubMed ID: 4283417
    [No Abstract]   [Full Text] [Related]  

  • 10. Parkinsonism and levodopa: a five-year experience.
    Delaney P; Fermaglich J
    J Clin Pharmacol; 1976; 16(11-12):652-9. PubMed ID: 791974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metoclopramide and pimozide in Parkinson's disease and levodopa-induced dyskinesias.
    Tarsy D; Parkes JD; Marsden CD
    J Neurol Neurosurg Psychiatry; 1975 Apr; 38(4):331-5. PubMed ID: 1095689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short- and long-term approaches to the "on-off" phenomenon.
    Papavasiliou PS; Cotzias GC; Mena I
    Adv Neurol; 1974; 5():379-86. PubMed ID: 4440585
    [No Abstract]   [Full Text] [Related]  

  • 13. Six years of high-level levodopa therapy in severely akinetic parkinsonian patients.
    Barbeau A
    Arch Neurol; 1976 May; 33(5):333-8. PubMed ID: 817698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variations in the "on-off" phenomenon.
    Duvoisin RC
    Adv Neurol; 1974; 5():339-40. PubMed ID: 4440582
    [No Abstract]   [Full Text] [Related]  

  • 15. L-dopa, parkinsonism, and involuntary movements.
    Mayer RF
    Trans Am Neurol Assoc; 1974; 99():163-6. PubMed ID: 4463527
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasma levodopa and the "on-off" effect.
    Caine DB; Claveria LE; Allen JG
    Adv Neurol; 1974; 5():341-4. PubMed ID: 4440583
    [No Abstract]   [Full Text] [Related]  

  • 17. Unexpected findings with apomorphine and their possible consequences.
    Cotzias GC; Mena I; Papavasiliou PS; Mendez J
    Adv Neurol; 1974; 5():295-9. PubMed ID: 4440577
    [No Abstract]   [Full Text] [Related]  

  • 18. "Off period" dystonia and "on period" choreoathetosis in levodopa-treated patients with Parkinson's disease.
    Lees AJ; Shaw KM; Stern GM
    Lancet; 1977 Nov; 2(8046):1034. PubMed ID: 72935
    [No Abstract]   [Full Text] [Related]  

  • 19. Controversies in the treatment of Parkinson's disease.
    Hershey LA
    Ration Drug Ther; 1985 Feb; 19(2):1-4. PubMed ID: 4048474
    [No Abstract]   [Full Text] [Related]  

  • 20. Six-year results of treatment with levodopa plus benzerazide in Parkinson's disease.
    Barbeau A; Roy M
    Neurology; 1976 May; 26(5):399-404. PubMed ID: 944392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.